Oral Semaglutide Versus Empagliflozin in Patients With Type 2 Diabetes Uncontrolled on Metformin: The PIONEER 2 TrialHelena W. Rodbard, Е. О. Филиппова, Julio Rosenstock et al.|Diabetes Care|2019Cited by 442
Association of obesity with cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: Insights from TECOSNeha J. Pagidipati, Eric D. Peterson, Robert J. Mentz et al.|American Heart Journal|2019Cited by 77